Ceterix Orthopaedics: Develops novel surgical tools for arthroscopic procedures.

(MENAFNEditorial) iCrowdNewswire - Jul 26, 2017 Ceterix Orthopaedics

Menlo Park, CA 94026, US
Biotechnology

Ceterix Orthopaedics, Inc. develops novel surgical tools for arthroscopic procedures. The Ceterix technology enables surgeons to place stitches in very tight joint compartments, while protecting sensitive surrounding structures such as nerves, arteries and cartilage. This technology has applications in numerous arthroscopic procedures in knees, hips and shoulders.

Ceterix was established in October 2010. The company was founded based on the inventions of Dr. Justin Saliman, an orthopaedic surgeon specializing in sports medicine. Dr. Saliman envisioned improving the outcomes of arthroscopic procedures by enabling surgeons to place suture patterns that today can be done only in open procedures, if at all. Ceterix is based in Menlo Park, California.

John has 27 years of sales, marketing, and general management experience in medical devices. John started his career at American Hospital Supply (acquired by Baxter International) and has spent the past 20 years at start-ups, including DVI (acquired by Eli Lily), Perclose (acquired by Abbott Laboratories), Emphasys Medical (acquired by Pulmonx) and Ventus Medical. He has served on numerous Boards including Emphasys Medical, Ventus Medical, Disc Dynamics, Zeltiq (ZLTQ), Advanced Stent Technologies (acquired by Boston Scientific) and LuMend (acquired by Johnson & Johnson).

John holds B.A. degrees in Economics and Psychology from the University of California, Los Angeles and an M.B.A. from the UCLA Anderson Graduate School of Management.

David Heagy joined Ceterix in September of 2012 as our Vice President of Sales & Marketing. Mr. Heagy has 21 years of extensive experience in medical devices introducing new technologies in aesthetics, orthopedics, interventional cardiology, and laparoscopic surgery. He served at Zeltiq Aesthetics as Vice President of North American Sales from April 2010 until May 2012 and had previously served as Director of Sales since March 2008. He served as Western Regional Sales Director at Sciton, Inc., a manufacturer of aesthetic lasers, from March 2005 to February 2008.

He also has been employed at Thermage, Oratec Interventions, Sulzer Spinetech, Boston Scientific, and U.S. Surgical in various sales and sales management positions. Mr. Heagy brings to the company skill and expertise in developing sales organizations and launching new technologies.

Mr. Heagy earned his B.A. in Marketing from the University of Florida.

Michael has over 15 years of engineering and product development experience. Prior to joining Ceterix, Michael was Vice President of R & D at The Foundry, NewCo XI. He was Director of R & D at Emphasys Medical, R & D Manager at Cardica, Inc., and Mechanical Design Engineer at IDEO. Michael is a co-inventor on over 50 issued and pending U.S. patents.

He received an MS in Mechanical Engineering from Stanford University and a BS in Mechanical Engineering from Northwestern University.

Rich has over 25 years of quality assurance and regulatory affairs experience. Prior to joining Ceterix, Rich was Vice President of RA/QA at Pulmonx and Emphasys Medical. He also has been employed at Perclose, Spectranetics and USCI (Bard) in various engineering and management positions.

He received a BS in Mechanical Engineering from Rensselaer Polytechnic Institute.

Dr. Saliman is a sports medicine and arthroscopy -trained orthopaedic surgeon maintaining an active practice at the Cedars-Sinai Orthopaedic Center in Los Angeles, California. He specializes in joint-preserving treatment of injuries to the shoulder, hip and knee. Dr. Saliman completed a sports medicine fellowship at Stanford University / SOAR in Palo Alto where he provided care for the San Francisco 49ers and for Stanford University and Santa Clara University athletic teams. His residency in orthopaedic surgery was completed at St. Lukes-Roosevelt Hospital Center of Columbia University in New York City.

He earned his medical degree at the University of Colorado School of Medicine in his home town of Denver.

Dr. Saliman is at the forefront of innovation on minimally invasive devices, implants and techniques to repair injured or degenerative joints.

Charles Warden is a Menlo Park-based Managing Director.

Charles has been a medical device venture investor since 1992. He works closely with entrepreneurial device companies every step of the way, from inception to success. Prior to joining Versant he was a general partner at Schroder Ventures Life Sciences (now SV Life Sciences) where he led the SV medical device effort.

Previously, Charles worked with Boston Capital Ventures, where he concentrated on medical device and other healthcare investments. Before becoming a venture capitalist, Charles was a consultant with Monitor Company, a strategy consulting firm.

Charles has been actively involved with The Innovation Factory, a medical devices incubator, since its beginnings in 1999. He is also involved in ForSight Labs, an ophthalmic incubator, and with The Foundry, a medical devices incubator.

Mark S. Colella joined 5AM Ventures in 2008 from BRRX Medical, a Bay Area start-up gastrointestinal medical device company, where he was head of marketing.

Prior to BRRX, he held various management roles with Stryker, focused in the fields of orthopedics, laparoscopy, urology, gynecology, and general minimally invasive surgery. Mr. Colella brings over a decade of operational experience in healthcare, focused primarily in the areas of marketing, product development and business development. In addition, he spent four years with Primrose Alzheimer's Living, Inc., an early-stage healthcare service start-up company, and one year working for Versant Ventures.

Mr. Colella currently serves on the boards of Semprus Biosciences and represents 5AM as a board observer to WaveRx, TivaMed and Epic Pharmaceuticals.

Mr. Colella earned a B.S. in Biology from Williams College and earned his M.B.A. from Northwestern University, the Kellogg School of Management. Mr.

Peter joined Novo Ventures (US) Inc. in San Francisco, California in 2009. He is a member of the Board of Directors of Alder Biopharmaceuticals Inc., Asante Solutions Inc., Ceterix Orthopaedics Inc., HTG Molecular Diagnostics Inc., Nevro Corporation, Otonomy Inc. and Thesan Pharmaceuticals Inc. Previously, he was a board member of several EU and US companies.

From 2001-2009, Peter was employed with Novo A/S as a partner in Novo Ventures. Prior to joining Novo A/S he was with McKinsey & Co. as a general consultant and as a specialist within the Scandinavian Corporate Finance and Strategy Group. At McKinsey, Peter focused on strategy development, mergers, acquisitions and alliances in various industries.

Peter is the co-author of ‘Growth by Mergers & Acquisitions' published by Brsens Forlag, 2004.

Dr. Makower is the CEO and Founder of ExploraMed Development, LLC, a medical device incubator based on the west coast. He is also a Venture Partner with New Enterprise Associates where he supports the investing activity in the medical device arena. Josh serves as a Consulting Associate Professor of Medicine at Stanford University Medical School and co-founded Stanfords Biodesign Innovation Program.

Josh has founded several companies through the ExploraMed incubator, which have achieved successful M & A transactions including Acclarent, Inc., a company focused on developing novel therapies in ENT. Josh also serves on the Board of Directors for NeoTract, Inc,, Moximed, Inc., Intrinsic Therapeutics, Inc., and Vibrynt, Inc. Josh holds over five dozen patents for various medical devices in the fields of Orthopaedics, ENT, Cardiology, General Surgery, Drug Delivery and Urology.

Effective June 1, 2004, Kevin Sidow began his role as President and Chief Executive Officer for St. Francis Medical Technologies, Inc.

Prior to joining SFMT, Kevin was the Worldwide President of DePuy Inc. As former Worldwide President of DePuy; Kevin oversaw the global orthopedic, spine, trauma, and sports medicine businesses and has over 20 years of orthopedic medical device experience. His responsibilities included the combined worldwide reconstructive business (hips, knee, extremities, operating room products, ACE and casting), Spine, Mitek (sports medicine) and Biologics with annual revenue responsibility of over $3 billion.

Kevin joined DePuy in March of 1998 as Midwest Area Vice President. He was promoted to Vice President, Sales, for DePuy Orthopaedics in October 1999 where he contributed significantly to the integration of the joints sales force while achieving record sales levels. He was promoted to President of DePuy Orthopaedics in August 2000.

MENAFN2607201700703403ID1095661417

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.